Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $300.10 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $204.39 | 15 | $0 (2019) |
| Eisai Inc. | $39.07 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $28.81 | 2 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $15.86 | 1 | $0 (2019) |
| PFIZER INC. | $11.97 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $67.14 | 5 | Genentech USA, Inc. ($39.31) |
| 2018 | $90.28 | 6 | Genentech USA, Inc. ($72.82) |
| 2017 | $142.68 | 10 | Genentech USA, Inc. ($92.26) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Metabolism & Primary Care | ||||||
| 08/15/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/16/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: CNS | ||||||
| 03/19/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Metabolism & Primary Care | ||||||
| 02/19/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Metabolism & Primary Care | ||||||
| 12/18/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Metabolism & Primary Care | ||||||
| 04/17/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Metabolism & Primary Care | ||||||
| 02/20/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Metabolism & Primary Care | ||||||
| 02/13/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Metabolism & Primary Care | ||||||
| 01/16/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Metabolism & Primary Care | ||||||
| 11/21/2017 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Metabolism & Primary Care | ||||||
| 09/19/2017 | Genentech USA, Inc. | Activase (Biological), Cathflo Activase | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Metabolism & Primary Care | ||||||
| 09/19/2017 | Genentech USA, Inc. | Activase (Biological), Cathflo Activase | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Metabolism & Primary Care | ||||||
| 08/17/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Neurology | ||||||
| 07/27/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $22.90 | General |
| Category: Neurology | ||||||
| 05/09/2017 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Metabolism & Primary Care | ||||||
| 03/21/2017 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Metabolism & Primary Care | ||||||
| 02/21/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2017 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Metabolism & Primary Care | ||||||
| 01/17/2017 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Metabolism & Primary Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 121 | 140 | $48,735 | $15,984 |
| 2022 | 6 | 295 | 363 | $112,967 | $36,805 |
| 2021 | 6 | 319 | 407 | $116,723 | $43,974 |
| 2020 | 6 | 393 | 528 | $130,652 | $56,085 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 38 | 40 | $30,480 | $6,283 | 20.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 63 | $9,450 | $5,637 | 59.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $5,538 | $2,579 | 46.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $3,267 | $1,484 | 45.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 80 | 92 | $70,104 | $14,639 | 20.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 118 | 173 | $25,950 | $13,504 | 52.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $7,425 | $3,581 | 48.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 42 | 42 | $5,418 | $3,220 | 59.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $2,982 | $1,349 | 45.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 16 | 17 | $1,088 | $513.47 | 47.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 132 | 206 | $30,900 | $16,724 | 54.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 72 | 76 | $57,912 | $13,033 | 22.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 66 | 66 | $19,602 | $10,417 | 53.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 22 | 22 | $4,004 | $1,787 | 44.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $2,769 | $1,286 | 46.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 24 | $1,536 | $727.20 | 47.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 127 | 221 | $33,150 | $18,402 | 55.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 103 | 107 | $31,779 | $17,142 | 53.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 59 | 59 | $44,958 | $10,481 | 23.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 65 | 101 | $10,605 | $5,837 | 55.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 27 | 28 | $5,096 | $2,380 | 46.7% |
| G0508 | Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | Office | 2020 | 12 | 12 | $5,064 | $1,843 | 36.4% |
About Dr. Reid Taylor, M.D
Dr. Reid Taylor, M.D is a Neurology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861467987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reid Taylor, M.D has received a total of $300.10 in payments from pharmaceutical and medical device companies, with $67.14 received in 2019. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($300.10).
As a Medicare-enrolled provider, Taylor has provided services to 1,128 Medicare beneficiaries, totaling 1,438 services with total Medicare billing of $152,849. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Asheville, NC
- Active Since 02/22/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1861467987
Products in Payments
- Activase (Biological) $204.39
- Fycompa (Drug) $39.07
- XARELTO (Drug) $28.81
- APTIOM (Drug) $15.86
- ELIQUIS (Drug) $11.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Asheville
James Patton, Md, MD
Neurology — Payments: $262,720
Robert Armstrong, Md, MD
Neurology — Payments: $142,313
Dr. Matthew Engelbrecht, M.d, M.D
Neurology — Payments: $51,456
Dr. Lei Lu
Neurology — Payments: $2,910
Alexander Schneider, M.d, M.D
Neurology — Payments: $1,133
Anna-Marieta Moise, M.d, M.D
Neurology — Payments: $1,118